Healio - Hepatitis C
Antivirals may cure HCV–associated B-cell lymphoma, case study findsMarch 31, 2017
Treatment with direct-acting antivirals may result in remission of hepatitis C virus-associated lymphoma, researchers suggested.
The case study’s findings suggest that “elimination of the causative pathogen could be essential for the treatment of HCV-associated NHL even without an interferon (IFN)–based treatment,” they added.
From May to August of 2016, the patient received daily doses of the DAA combination Harvoni (sofosbuvir/ledipasvir, Gilead Sciences) to treat HCV. The researchers reported no major complications.
Continue reading....
The case study’s findings suggest that “elimination of the causative pathogen could be essential for the treatment of HCV-associated NHL even without an interferon (IFN)–based treatment,” they added.
From May to August of 2016, the patient received daily doses of the DAA combination Harvoni (sofosbuvir/ledipasvir, Gilead Sciences) to treat HCV. The researchers reported no major complications.
Continue reading....
No comments:
Post a Comment